Table 2.
Baseline characteristics and thrombotic outcomes in the outpatient populations.
| Patients discharged from the medical ward (n = 140) |
Patients discharged from the rehabilitation ward (n = 35) |
|
|---|---|---|
| Median age – yr [IQR] | 63 [48–75] | 82 [75–89] |
| Males – n (%) | 75 (54) | 13 (37) |
| Residency at discharge | ||
| Home – n (%) | 106 (76) | 9 (26) |
| Retirement home – n (%) | 19 (14) | 17 (49) |
| Long-term care facility – n (%) | 15 (11) | 9 (26) |
| Length of stay – median days [IQR] | 11,5 [6–21] | 19 [13–28] |
| ICU stay – n (%) | 24 (17) | 0 |
| Length of stay (ICU) – median days [IQR] | 15 [6–23] | – |
| Comorbidities | ||
| Smoking | ||
| Never – n (%) | 121 (86,4) | 31 (88,6) |
| Past or active – n (%) | 19 (13,6) | 4 (11,4) |
| COPD – n (%) | 11 (8) | 4 (11,4) |
| CAD – n (%) | 21 (15) | 15 (43) |
| Hypertension – n (%) | 65 (46) | 26 (74) |
| Dyslipidemia – n (%) | 45 (32) | 16 (46) |
| Diabetes – n (%) | 37 (27) | 14 (40) |
| Stroke – n (%) | 6 (4,3) | 8 (23) |
| Atrial fibrillation – n (%) | 17 (12) | 9 (26) |
| Past history of VTE – n (%) | 3 (2,1) | 0 (0) |
| Cancer – n (%) | 16 (11) | 1 (2,9) |
| Immunosuppressed – n (%) | 10 (7.1) | 1 (2,9) |
| Anticoagulation at discharge – n (%) | 14 (10) | 10 (29) |
| Thromboprophylaxis at discharge – n (%) | 0 | 0 |
| Thrombotic outcomes | ||
| Total – n (%) | 1 (0,71) | 0 (0) |
| Venous – n (%) | 1 (0) | 0 (0) |
| Arterial – n (%) | 0 (0) | 0 (0) |